Publicaciones en colaboración con investigadores/as de Hospital Universitario La Fe (19)

2023

  1. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

2022

  1. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

2021

  1. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure

    Frontiers in Physiology, Vol. 12

2020

  1. Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction

    Open Heart, Vol. 7, Núm. 2

2019

  1. Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity

    Journal of the American College of Cardiology, Vol. 73, Núm. 7, pp. 779-791

2017

  1. Dynamic edematous response of the human heart to myocardial infarction: Implications for assessing myocardial area at risk and salvage

    Circulation, Vol. 136, Núm. 14, pp. 1288-1300

2016

  1. Comparison of 1-Year Outcome in Patients with Severe Aorta Stenosis Treated Conservatively or by Aortic Valve Replacement or by Percutaneous Transcatheter Aortic Valve Implantation (Data from a Multicenter Spanish Registry)

    American Journal of Cardiology, Vol. 118, Núm. 2, pp. 244-250

2009

  1. Patient registries of acute coronary syndrome assessing or biasing the clinical real world data?

    Circulation: Cardiovascular Quality and Outcomes, Vol. 2, Núm. 6, pp. 540-547

1995

  1. Chronic rejection in 500 kidney transplant patients treated with cyclosporine: Incidence and risk factors

    Transplantation Proceedings

1994

  1. Analysis of the risk factors of late failure in renal transplantation under cyclosporine immunosuppression

    Transplantation Proceedings

  2. INSUFICIENCIA RENAL AGUDA TRAS LA ADMINISTRACION DE ENALAPRIL COMO FORMA DE PRESENTACION DE LA ARTERITIS DE TAKAYASU

    Medicina Clinica, Vol. 102, Núm. 2, pp. 60-63

  3. Interaction between probucol and cyclosporine in renal transplant patients

    Annals of Pharmacotherapy, Vol. 28, Núm. 7-8, pp. 940-943

  4. M. kansasii infection of the lung after cytomegalovirus pneumonia in a kidney transplant patient

    Archivos de Bronconeumologia, Vol. 30, Núm. 4, pp. 222-225

1992

  1. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation

    Transplantation Proceedings

  2. Five-year experience with a triple drug protocol in renal transplantation

    Transplantation Proceedings

  3. Risk factors and prognostic significance of hypertension after renal transplantation

    Transplantation Proceedings

  4. Six-year experience with a triple drug protocol in renal transplantation: Analysis of risk factors

    Transplantation Proceedings

  5. Triple drug maintenance therapy in renal transplantation

    Transplantation Proceedings

1991

  1. INFLUENCIA DE LA EDAD DEL DONANTE SOBRE LA FUNCION DEL INJERTO Y LA SUPERVIVENCIA DEL TRASPLANTE RENAL

    Nefrologia, Vol. 11, Núm. SUPPL. 1, pp. 127-132